Clinical Cancer Advances 2021: ASCO’s Report on Progress Against Cancer

Sonali M. Smith, Kerri Wachter, Howard A. Burris, Richard L. Schilsky, Daniel J. George, Douglas E. Peterson, Melissa L. Johnson, Merry Jennifer Markham, Kathryn F. Mileham, Muhammad S. Beg, Johanna C. Bendell, Robert Dreicer, Vicki L. Keedy, Randall J. Kimple, Miriam A. Knoll, Noelle LoConte, Helen MacKay, Jane Lowe Meisel, Timothy J. Moynihan, Daniel A. MulrooneyTherese Marie Mulvey, Olatoyosi Odenike, Nathan A. Pennell, Katherine Reeder-Hayes, Cardinale Smith, Ryan J. Sullivan, Robert Uzzo

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Abstract

Clinical Cancer Advances 2021: ASCO’s Report on Progress Against Cancer highlights the most important clinical research advances of the past year and identifies priority areas where ASCO believes research efforts should be focused moving forward. This year’s report also discusses the critical issue of health equity in cancer research and solutions to ensure that every patient with cancer, everywhere, can access the latest advances.

Original languageEnglish (US)
Pages (from-to)1165-1184
Number of pages20
JournalJournal of Clinical Oncology
Volume39
Issue number10
DOIs
StatePublished - Apr 1 2021

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Clinical Cancer Advances 2021: ASCO’s Report on Progress Against Cancer'. Together they form a unique fingerprint.

Cite this